Clinical Features and Treatment Outcome of a Concurrent Central Retinal Vein Occlusion and Cilioretinal Artery Occlusion

• Published in: Case reports in ophthalmology Vol. 13; no. 3; pp. 770 - 776
• Main Authors: Tesfaw, Alemu Kerie, Batra, Nikhil N., Phan, Cong T.
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 10.10.2022; Karger Publishers
• Subjects: Atrophy; Case Report; Case reports; central retinal vein occlusion; cilioretinal artery occlusion; Diabetic retinopathy; Edema; Hemodynamics; Hypotheses; Medical imaging; Monoclonal antibodies; Ophthalmology; Photography; Retina; Veins & arteries; Visual acuity; Wool; Cilioretinal artery occlusion; Central retinal vein occlusion
• ISSN: 1663-2699; 1663-2699
• DOI: 10.1159/000525442

We describe the clinical features and treatment outcome of a patient with combined central retinal vein occlusion and cilioretinal artery occlusion. A 52-year-old female presented to our clinic with decreased vision in the right eye for 4 days. Visual acuity and intraocular pressure were count fingers at 2&1/2M and 14 mm Hg in the right and 20/20 and 16 mm Hg in the left eye, respectively. Funduscopic exam and optical coherence tomography (OCT) of the right eye confirmed the diagnosis of concurrent cilioretinal artery occlusion and central retinal vein occlusion with segmental macular pallor in the territory of the cilioretinal artery, corresponding marked inner retina thickening on OCT and signs of vein occlusion. The patient received an intravitreal injection of bevacizumab and at 1-month follow-up, vision improved to 20/30 with corresponding anatomical improvement. It is very important to recognize combined central retinal vein occlusion and cilioretinal artery occlusion as they could be treated with intravitreal injections of anti-vascular endothelial growth factors with favorable treatment outcomes.